Corporate
Gossamer Bio Stock Crashes 78% as Seralutinib Narrowly Misses Phase 3 Endpoint, Still Eyes FDA Path
4d ago
You're signed outSign in or to get full access.
Leadership at Gossamer Bio
Browse executives, board members, and key leadership.
Executives at Gossamer Bio
Faheem Hasnain
President, Chief Executive Officer and Chairman
CEO
Executive
Board
Bob Smith
Chief Commercial Officer
Executive
Bryan Giraudo
Chief Operating Officer and Chief Financial Officer
Executive
Caryn Peterson
Executive Vice President, Regulatory
Executive
Christian Waage
Executive Vice President, Technical Operations and Administration
Executive
Richard Aranda
Chief Medical Officer
Executive